Member Info for Ecologist

I believe that this latest news and its repercussions on production will be treated very negatively come Monday morning, unless Orion or someone else steps in with replacement funds. However, the rns does how thin is tye ice that BMN is skating on. To misquote Queen Victoria "I am f'ing not amused"

And a happy Fooking new year to us all.

Sammy (we are seriously off topic), in my book ww3 has been underway for a long time and I don't put a ring around the Middle East and call that the cinema of actions. Terrorist strikes across Europe, coup d'états in Africa and uncontollable imigration are just some of the modern weapons of this war. We live in a sad old world.

Haleon (market cap of around $40 billion) or Pfizer (at about $170 billion)? I think Pfizer would rather add FUM to its stable than allow Haleon to get a foot in the ED door. So a bidding war could become very interesting.

My thoughts too Scoredagainsteps, presumably for the same reason with the appointment of Roy Davis to the board (?) Where Roy goes, takeovers follow.

Lol Toli, and it's not even April 1st.

I would love your prediction to come true but the sp needs a bucket load of the magic gel.

I note midday's RNS that Portillon have just been awarded an option over 45 million shares at 3p.

Am I interpreting the RNS incorrectly when it seems that Portillon cannot lose here? As an option, if the sp does not reach 3p, they let it lapse and if it passes 3p they are in profit; thank you very much.

Please tell me I'm wrong because this smells like a buddy deal.

Could M&P be picking up shares at a slightly cheaper price?

I voted against the t/o last year but when the majority vote went for the deal, decided to put the equivalent amount into M&P. Almost a 100% return, so no moans from me.

No Mikinaman, they simply stutter.

All to their own but I am unclear why a PI would pay 3p through PrimaryBid (and then not be assurred of the outcome) rather than 2.6p in the market.

Sadly the deal did not put very much cash in the bank! I confess to having been surprised that Prospex did not make a move for Coro's Italian assets, after all they are dripping with cash from their own Italian production and from their Spanish ones.

@StockCheque Just a small reminder that Aminex is not an AIM stock despite often acting like one.

Fumble Medical in all its glory

Fuzzbox, too true. I rip into restaurants, hotels and the like with my comments when the service / product is awful but when it does what is says on the can, I usually forget to say so.

So great, we have the recognition from Boots. Let's hope that our reward follows closely behind.

Quarter's result out. Now we know why the sp has lost 20% odd over the last few weeks. I hope IO09 is not as leaky as the boardroom.

As a shareholder of both Went and M&P, @Blackgold, I don't think i have yet 'heard the fat lady sing'. As far as I know, the deal is still ongoing. But agreed it was on the cheap given Went's cash in the bank; exactly the reason I bought into the French company at around €3.30 if memory is correct.

Fumble Medical, BoD dropping the ball again in their greedy rush to the trough. I sincerely believe that our only hope of a decent price rise is to be swallowed, and quick.

@Pageofcups: isn't pattern trading what everyone tries to do? I mean find a trend and trade it. I noticed a while back that AirBnB peaks and then falls before peaking again. For the past couple of years I have been trading in and out of the BnB stock. Usually selling just after results come out.

Why should investors not try to play the trends? You get no reward from faithfully watching a stock that goes up and down (or just down) like a yoyo. I have a small position in AEX but happily sell when the sp runs away with itself and buy when it falls to silly levels. AEX may not be an AIM stock but it sure acts like one and I'm happy to take, say, 30% when its on offer.

After the rns this morning it looks like they are seeking the fools locally. The money raise appears to be more a sop to a near future labour government than a commercial venture. I don't like the look of it and in 30 minutes we'll see what the market thinks!

Stanaccy can you talk us through your reasoning because I doubt any current investors would agree with you?